John Kerr posted in cancer • oncology • SMCC • viral therapy • virus on September 1st, 2011.
Scientists are cautiously optimistic about a trial cancer therapy which uses a virus to selectively kill tumor cells. Canadian researchers have completed the first clinical trial in which viral therapy is delivered to cancer patients intravenously, and the virus selectively replicates only within tumour cells. The trial, published in Nature this week, show promising results. […]
Continue reading “Viral cancer therapy shows early promise – experts respond”